HDAC inhibitor developed at Enzo Life Sciences. Inhibits HDAC activity in HeLa nuclear extracts (IC50=5-10µM).
Product Details
| Formula: | C20H25N3O2 |
| |
| MW: | 339.4 |
| |
| CAS: | 537034-17-6 |
| |
| Purity: | ≥98% (TLC) |
| |
| Appearance: | Tan solid. |
| |
| Solubility: | Soluble in DMSO (25mg/ml) or 100% ethanol (10mg/ml, warm) |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia: D. Herman, et al.; Nature Chem. Biol.
10, 551 (2006),
Abstract;
The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines: J. Savickiene et al.; Eur J Pharmacol
549, 9 (2006),
Abstract;
